Molecular testing in the diagnosis and management of chronic hepatitis B - Wikidata - wikimedia - TriplyDB

Molecular testing in the diagnosis and management of chronic hepatitis B

Molecular testing in the diagnosis and management of chronic hepatitis B

http://www.wikidata.org/entity/Q36881140

about

Update on hepatitis B and C virus diagnosis Hepatitis B virus infection: An insight into infection outcomes and recent treatment options Rapid and quantitative detection of hepatitis B virus Molecular mechanisms underlying occult hepatitis B virus infection.Diagnosis of hepatitis B Detection of Hepatitis B Virus M204I Mutation by Quantum Dot-Labeled DNA Probe.Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays.Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities Association of glutathione S-transferase T1 and M1 genotypes with chronic liver diseases among Filipinos.MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis.Prevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam.Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China.A Study on the Age-Related Changes in Hepatitis B and C Virus Serology Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification.A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).Hepatitis B virus genotypes among chronic hepatitis B patients reporting at Korle-Bu teaching hospital, Accra, Ghana.Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy Oral fluid and hepatitis A, B and C: a literature review.Current information on the immunologic status of occult hepatitis B infection.Diagnostic markers for hepatitis virus infection.Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.Aptamer-based competitive binding assay for one-step quantitation of hepatitis B surface antigen.Development and Implementation of Autoverification Rules for ELISA Results of HBV Serological Markers.A comparison of hepatitis B seroepidemiology in ten European countries.Molecular diagnosis of entecavir resistance Analysis of hepatitis B virus genotype changes in patients with chronic hepatitis B infection on tenofovir therapy.Occult hepatitis B virus infection among people with a family history of chronic hepatitis B virus infection.Association of human leukocyte antigen haplotypes with clearance and persistence of hepatitis B virus infection in northeastern China.Expression of the hepatitis B virus surface antigen in Drosophila S2 cells Introduction of an automated system for the diagnosis and quantification of hepatitis B and hepatitis C viruses.Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.Association between HBsAg positivity and pancreatic cancer: a meta-analysis.Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus.Quick genotyping detection of HBV by giant magnetoresistive biochip combined with PCR and line probe assay.How to compare antivirals in the treatment of chronic hepatitis B?Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus.Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia.Comparison of Hybrid Capture 2 Assay with Real-time-PCR for Detection and Quantitation of Hepatitis B Virus DNA

P2860

Q26777048-C0A77344-F37B-44F9-BF4C-7F0DCB35FB60 Q26782127-7EDDC4EE-2A2A-41A0-9649-058C5F72502E Q26852749-5DE9C419-BFCB-49BD-85FC-9DA7EF3CD63A Q27686923-C1A6F664-0179-44A7-86D5-1969090F7E29 Q28071817-07D4ADA9-58D8-4904-B13A-CD90B27CE219 Q33769738-1CAF0F9A-73A0-4D34-B709-A84F9D9B370F Q33780105-2E2D7254-1D5A-4AEC-AF86-31F291B48D93 Q35356381-004D12F8-4679-4DE9-8CEC-0C82EECD6FA5 Q35603758-9A6DB5DE-3829-45B2-99FD-CF5DCC2448B2 Q36038286-8E5D42B3-2487-4CF6-A2BF-7CBC8FADCFE3 Q36146616-9406AC3B-02E8-46B0-AA55-2F07CEBD86B3 Q36289650-8F4B9991-454B-4D43-AEBB-21D52E9BBC18 Q36516176-C9E134DF-058A-4CA1-B937-E45F1FA03B5C Q36688773-5BF5C49C-27EB-4CEA-8BE6-BF7BF12EA24F Q36689718-BAEAECA8-15B1-4DDE-BD55-4785EF7110FB Q37036994-6E87374A-081D-4F74-B08F-DB9A528875C4 Q37624794-24FDE41B-062B-4379-B450-F710082E3FF7 Q37632321-44BA88BE-0938-4729-B392-8FBA2CFB83EA Q37970474-A8F1475D-AA19-4AD5-9172-CE170F166C01 Q37992140-84D49E92-44F9-44C3-9351-63E3586BEF8F Q38089735-7A40AEC7-A52E-4ED0-A224-82E49D59213B Q38167708-DB1B980F-5769-4321-A12E-FB6A017D3D57 Q38306046-E5C2C3E1-A513-42E1-8205-CC9CA240E052 Q38574579-179D7089-8DCA-4C4C-A09F-98F7E5BF8B52 Q40016555-33B02282-5194-49FB-9012-E14973214474 Q40789723-EF0BC995-3792-41C7-9834-5DF325461760 Q40799373-7408AB1B-45FA-4A6F-B302-BE6DB88C2968 Q41239881-E6FCCA2D-FB6B-4F52-A36B-37F9170E469C Q41542632-69FB29A1-AE6F-40FF-BE95-9606E367660C Q41775312-9DC7DBCE-1EA4-462F-9E99-3422F1862A93 Q41809253-A075CFCA-9BFC-43AE-BA4B-ADB0EDFFFC07 Q42000973-2D373B6D-DC66-407C-A173-6D03EF334814 Q42221054-2C0E1A1F-CF3F-4792-959A-9F31A877FDB8 Q42725988-E6DCCF20-0631-4796-BA99-2EEBAF5D70A6 Q43046963-731E95FD-CE05-40CB-9B60-896CD566CBB6 Q43166972-2B924F6F-7C8F-4591-A9D6-3E637202BCDC Q45365125-CB09B139-9608-40ED-AAE8-433E40CAFD08 Q50026728-A9CFB6D1-534D-4025-85DF-B29C105B1DC8 Q57930933-C2930BDE-416B-42B2-8B45-E7435692E108

P2860

Molecular testing in the diagnosis and management of chronic hepatitis B

http://www.wikidata.org/entity/Q36881140

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Molecular testing in the diagnosis and management of chronic hepatitis B

@en

type

label

Molecular testing in the diagnosis and management of chronic hepatitis B

@en

prefLabel

Molecular testing in the diagnosis and management of chronic hepatitis B

@en

P1433

Q36881140-93EDF556-FD78-43DC-B60A-6FDBDB6C68F5

P1476

Q36881140-AFD7E02C-E901-405A-8DC0-DC48C76125C0

P2093

Q36881140-AECA17FC-8257-4558-A60D-F39A2FDF0E57

P2860

Q36881140-00033CF0-7888-42B3-8477-6CE23F55263F

Q36881140-0056732E-7BE5-4012-9AFE-C596336BD6A1

Q36881140-02BDF2B7-6A10-4BD6-AD75-48D936133F01

Q36881140-035A6E48-DF50-470F-8EB1-3E9B55F5AC1D

Q36881140-04AB6377-237E-4699-AB20-3F848E9E32B6

Q36881140-04F6791A-7F9C-4896-B504-DB6D9CD79E5E

Q36881140-053E7C0F-7AD9-466C-97A2-54281B1CF201

Q36881140-0818D4E6-F5B6-4F3A-8E1C-22C474DB0E97

Q36881140-08530C9D-5FE5-4356-B313-FD484DC732B5

Q36881140-0985DE4F-0BEB-42DB-AFF8-EF77C9FE5006

P304

Q36881140-D37320AB-E22E-4F8D-A7A2-07B1698FB33B

P31

Q36881140-32484358-E204-49AC-AC45-3B0AF26F5960

P356

Q36881140-0467D65A-B54E-4E22-A6FD-1820A275941A

P407

Q36881140-B13BE018-A07B-4F31-ACB7-8F69A526F40F

P433

Q36881140-38B33377-955F-4B04-881A-676AB650CEA5

P478

Q36881140-9324563C-2F17-4BAD-9E14-9C48891D1E54

P577

Q36881140-D66152AF-F128-41E0-B510-49DDA5B7CE0D

P5875

Q36881140-ACCE0514-06E8-4D48-B58E-B70C71D47762

P698

Q36881140-ABAC2E43-4CE6-4122-AE4C-87F769424073

P932

Q36881140-E042DB36-8F0A-4237-B056-5E48FE6E54FF

P356

P1433

Clinical Microbiology Reviews

P1476

Molecular testing in the diagnosis and management of chronic hepatitis B

@en

P2093

Alexandra Valsamakis

http://www.w3.org/2001/XMLSchema#string

P2860

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

Evaluation of the COBAS amplicor HBV monitor assay and comparison with the ultrasensitive HBV hybrid capture 2 assay for quantification of hepatitis B virus DNA

Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group.

Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America.

Identification of different states of hepatitis B virus infection with a quantitative PCR assay

P304

426-39, table of contents

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CMR.00009-07

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6208555

http://www.w3.org/2001/XMLSchema#string

P698

17630333

http://www.w3.org/2001/XMLSchema#string

P932

1932755

http://www.w3.org/2001/XMLSchema#string